Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.21%
1,087.23
-13.34
-1.21%
1,100.571,098.941,103.801,085.72
SIXC
Communications
SIXC
Communications
SIXC
-0.10%
604.54
-0.61
-0.10%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.16%
1,209.08
+13.89
+1.16%
1,195.191,204.711,217.721,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-1.33%
1,716.82
-23.09
-1.33%
1,739.911,734.501,734.501,713.35
SIXM
Financials
SIXM
Financials
SIXM
+0.35%
640.79
+2.23
+0.35%
638.56640.21645.32639.66
SIXR
Staples
SIXR
Staples
SIXR
+0.59%
836.48
+4.91
+0.59%
831.57840.48843.98834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.13%
213.63
+0.27
+0.13%
213.36213.36215.54212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.71%
3,178.84
-55.34
-1.71%
3,234.183,171.863,195.363,156.24
SIXU
Utilities
SIXU
Utilities
SIXU
+0.03%
935.83
+0.25
+0.03%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.40%
1,455.11
+5.85
+0.40%
1,449.261,454.771,462.651,453.46
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.52%
2,370.03
-12.42
-0.52%
2,382.452,371.192,380.452,367.31
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
₹648.00
+4.18%
(+26.00) 1D
Apr 28, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
₹622.00
High
₹648.00
Low
₹610.65
Mkt. cap
13.01B
Avg. vol.
39.11K
Volume
130.71K
Dividend
0.28%
Quarterly dividend
₹0.45
Ex dividend date
Sep 12, 2025
P/E ratio
14.77
52-wk high
₹677.00
52-wk low
₹440.00
EPS
₹43.86
Shares outstanding
20.00M
No. of employees
2K
News stories
From sources across the web
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1.85K
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
Feb 18, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -INR
Revenue / Estimate
1.66B/ (- est.)INR
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.68B
1.54B
1.63B
1.66B
Cost of goods sold
858.82M
693.84M
767.46M
759.60M
Cost of revenue
858.82M
693.84M
767.46M
759.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
330.92M
317.57M
303.56M
306.18M
Operating expense
576.65M
643.55M
648.09M
704.87M
Total operating expenses
1.44B
1.34B
1.42B
1.46B
Operating income
246.36M
203.27M
218.09M
198.75M
Other non operating income
-302.44M
152.72M
72.32M
151.46M
EBT including unusual items
162.46M
353.89M
288.11M
347.22M
EBT excluding unusual items
103.02M
353.89M
288.11M
347.22M
Income tax expense
46.72M
77.14M
88.27M
61.22M
Effective tax rate
28.75%
21.80%
30.64%
17.63%
Other operating expenses
209.11M
291.21M
308.34M
361.49M
Net income
115.75M
276.75M
199.84M
286.00M
Net profit margin
6.88%
17.96%
12.23%
17.20%
Earnings per share
-
-
-
-
Interest and investment income
78.31M
-
-
-
Interest expense
-
-2.10M
-2.31M
-2.98M
Net interest expenses
78.31M
-2.10M
-2.31M
-2.98M
Depreciation and amortization charges
32.26M
34.77M
36.19M
37.21M
EBITDA
278.30M
235.52M
253.58M
230.69M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more